The evolving management of endocrine disorders induced by checkpoint inhibitors: insights from the CIITED group
{{output}}
Introduction: Immune checkpoint inhibitor (ICI) induced endocrinopathies are a commonly encountered immune-related adverse event during cancer treatment. Several oncology and endocrinology groups have put together guidelines on t... ...
